Celadon Pharmaceuticals PLC Financial Flexibility Index
Celadon Pharmaceuticals PLC financial flexibility index. Celadon Pharmaceuticals PLC (CEL) has a Financial Flexibility Index of -0.21x as of June 2024. Free cash flow of GBX-1.26 Million (operating CF GBX-1.29 Million minus capex GBX29.50K) represents 0% of total liabilities (GBX6.01 Million). See CEL cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Celadon Pharmaceuticals PLC (2019–2023)
Financial flexibility index of Celadon Pharmaceuticals PLC from 2019 to 2023. Historical Financial Flexibility Index trend for Celadon Pharmaceuticals PLC across 5 annual periods. Explore CEL operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Celadon Pharmaceuticals PLC Financial Flexibility Index by Year (2019–2023)
Celadon Pharmaceuticals PLC financial flexibility index by year from 2019 to 2023. Year-by-year free cash flow to debt coverage for Celadon Pharmaceuticals PLC. For the full cash flow conversion analysis, see CEL cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.93x | GBX-5.63 Million | GBX-5.97 Million | GBX6.04 Million | ▼ -44.3% |
| 2022 | -0.65x | GBX-4.01 Million | GBX-6.10 Million | GBX6.21 Million | ▲ +95.1% |
| 2021 | -13.21x | GBX-2.61 Million | GBX-3.15 Million | GBX197.23K | ▼ -7960.8% |
| 2020 | 0.17x | GBX630.67K | GBX-77.57K | GBX3.75 Million | ▲ +21979.9% |
| 2019 | 0.00x | GBX1.98K | GBX1.98K | GBX2.60 Million | — |